Arbutus Appoints William Collier as Next President & CEO and Announces Retirement of Current President & CEO, Mark J. Murray Ph.D.

NEXT STORY
New Clinical Data Support the Utility of Epi proColon® Blood Test for Colorectal Cancer (CRC) Screening in Patients with Lynch Syndrome (LS), the Most Common Hereditary CRC Syndrome
PREV STORY
BeiGene Regains Full Global Rights to Its Investigational Anti-PD-1 Antibody Tislelizumab
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Shire plc : Director/PDMR Shareholding

Director/PDMR Shareholding May 3, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") ...

author_avatar
NASDAQ Market News

Equillium to Present Data at the 2020 American College of Rheumatology Meeting Demonstrating CD6 Modulation Improves Kidney and Skin Pathology in Preclinical Models of Systemic Lupus Erythematosus

author_avatar
NASDAQ Market News

Inovio Announces First Patient Dosed in Trial to Determine PENNVAX®-GP’s Ability to Induce Remission of HIV Infection

HIV Trial Will Be Fully Funded by $6.9 Million National Institutes of Health GrantPLYMOUTH ...

author_avatar
NASDAQ Market News